ScripsAmerica on Pace to Achieve Significant Revenue Growth in 2013 With Consecutive Record-Setting Months

NEW CASTLE, Del., March 6, 2013 (GLOBE NEWSWIRE) -- ScripsAmerica Inc. (OTCBB:SCRC), a leading supplier of prescription, OTC and nutraceutical drugs, today announced that the Company recorded its highest February revenue ever at $849,039, representing a 115% increase over February 2012.

In January, ScripsAmerica recorded its highest monthly revenue ever at $904,275 and its strong February sales put the Company on pace to achieve over $10,000,000 in revenue for 2013, which would represent a growth rate of 68% or higher over last year. With the anticipated product launch of its RapiMed® pediatric pain and fever reliever and acquisition of its pharmaceutical repackager, Marlex Pharmaceuticals, the Company expects to continue its steady growth.

"We are pleased to report a record start of 2013 to our shareholders, which management believes will be a breakout year for the company. ScripsAmerica is on pace to record our highest annual revenue ever and achieve an important milestone of $10 million in revenue. With our planned developments for the rest of this year, we are confident in our ability to continue this high rate of growth," stated CEO of ScripsAmerica, Bob Schneiderman.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. delivers pharmaceutical products to a wide range of end users across the health care industry through the largest pharmaceutical distributor in North America, McKesson Corporation. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. Current therapeutic categories serviced by the Company include pain, arthritis, prenatal, urinary, and hormonal replacement drugs. Other customers of ScripsAmerica include Cardinal Health, CutisPharma, Inc., MedVet and the United States Veterans Administration.

For more information, visit

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT: 888-959-7095Source:ScripsAmerica, Inc.